V. Likhachov, O. Taranovska, I. Zhabchenko, V. Oksyuta, V. Palapa, E. Krutikova
{"title":"慢性子宫内膜炎妇女早期妊娠失败的先决条件","authors":"V. Likhachov, O. Taranovska, I. Zhabchenko, V. Oksyuta, V. Palapa, E. Krutikova","doi":"10.24061/2413-4260.xiv.2.52.2024.9","DOIUrl":null,"url":null,"abstract":"The incidence of chronic endometritis is particularly high in women with spontaneous abortions, especially habitual ones. There are insuffi cient data on the mechanisms of miscarriage in women whose pregnancy occurred along with this pathology. Aim: to assess the level of synthesis of cytokines and endometrial proteins in women with CE in the preconceptional stage and in the early stages of pregnancy; to identify pathogenetic aspects of the impact of imbalance of these substances on the processes of pregnancy loss; to assess the possibility of correcting the identifi ed changes in the preconceptional stage. Materials and methods. The study was conducted in 2 phases. In the fi rst phase, 426 women with CE were studied (168 patients (group I) were treated for CE in the preconception period, and the rest, 258 patients (group II), did not receive treatment). The control group consisted of 30 healthy women. The levels of cytokines TNF-a, INF-γ, and IL-10 in cervical mucus and glycodelin in menstrual blood were determined by enzyme- linked immunosorbent assay. In the second phase of the study, women who became pregnant were followed: 135 women from group I who received preconceptional treatment for CE; 168 women from group II who became pregnant along with untreated CE; and 20 healthy women from the control group who became pregnant and subsequently had no complications. At 5-6 weeks of gestation, serum glycodelin concentration and cervical content levelsof TNF-a, INF-γ and IL-10 were determined. The data were processed using mathematical statistical methods, Student’s t-test, Pearson’s correlation coeffi cient (r) and odds ratio were evaluated using the STATISTICA program of StatSoft Inc. (USA). The study adhered to the tenets of the Declaration of Helsinki. The study protocol was approved by the local ethics committee of PSMU for all women enrolled in this study. The article is extracted from the initiative scientifi c research project of the Obstetrics and Gynecology Department No 2 of the Poltava State Medical University «Optimization of approaches to pregnancy management in women at high risk of obstetric and perinatal pathology» (term: 2022-2027; state registration number 0122U201228).Results and Discussion. At the preconceptional stage, patients with CE showed a signifi cant decrease in glycodelin levels by 2.9 times (p<0.05), an increase in proinfl ammatory cytokines (INF-γ by 2.8 times (p<0.001), TNF-α by half (p<0.001)), and a decrease in IL-10 by 2 times (p<0.001) compared to the levels in healthy non-pregnant women. A decrease in the level of glycodelin in menstrual blood of women with CE is inversely correlated with an increase in the level of proinfl ammatory cytokines in cervical mucus (both INF-γ; r= –0.77; p<0.05, and TNF-α; r= –0.69; p<0.05). At 5-6 weeks of gestation, the level of serumglycodelin was 14.5 % lower (р˂0.05) in patients with pregestational untreated CE and 58.6 % lower (p<0.001) in women with early pregnancy loss. The level of this protein in menstrual blood of women with CE before pregnancy was positively correlated with its concentration in serum at 5-6 weeks of pregnancy (r=0.61; p<0.01). Such a relationship was also characteristic for INF-γ (r=0.68; p<0.05) and TNF-α (r=0.78; p<0.05). An inverse correlation was also found between a decrease in glycodelin levels in the blood of pregnant women with a history of untreated CE at 5-6 weeks of pregnancy and an increase in TNF-α (r= –0.63; p<0.05) and INF-γ (r= –0.57; p<0.05) in the cervical mucus of these pregnant women at this stage of pregnancy. After treatment for CE, both in the preconceptional stage and in early pregnancy, an increase in glycodelin (р˂0.001), a decrease in INF-γ (p<0.05) and TNF-α (p<0.01), and an increase in IL-10 concentration (р˃0.05) were observed. The incidence of spontaneous abortion before 22 weeks’ gestation decreased 1.9-fold in women who received preconception treatment (OR 2.79; CI 95 % [1.45-5.38]; p < 0.05).Conclusions. In women with CE, there is a decrease in glycodelin synthesis and cytokine imbalance with an increase in proinfl ammatory cytokines: INF-γ (2.8-fold; р˃0.001) and TNF-α (twofold; p<0.001). The preconceptional decrease in glycodelin synthesis correlates with a decrease in synthesis of this protein by decidual cells after pregnancy, as well as with the prevalence of INF-γ and TNF-α in early pregnancy in women with a history of CE. This sets the stage for impaired immune tolerance between the uterus and the fetus and is one of the leading causes of spontaneous abortion in women who become pregnant with untreated CE. Preconceptional treatment of CE prevents the formation of cytokine imbalance and increases glycodelin synthesis in the early stages of pregnancy, which protects the course of pregnancy and reduces the incidence of early preterm labor by 4.6 times.","PeriodicalId":162458,"journal":{"name":"Neonatology, surgery and perinatal medicine","volume":" 21","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PREREQUISITES FOR EARLY PREGNANCY LOSS IN WOMEN WITH CHRONIC ENDOMETRITIS\",\"authors\":\"V. Likhachov, O. Taranovska, I. Zhabchenko, V. Oksyuta, V. Palapa, E. Krutikova\",\"doi\":\"10.24061/2413-4260.xiv.2.52.2024.9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The incidence of chronic endometritis is particularly high in women with spontaneous abortions, especially habitual ones. There are insuffi cient data on the mechanisms of miscarriage in women whose pregnancy occurred along with this pathology. Aim: to assess the level of synthesis of cytokines and endometrial proteins in women with CE in the preconceptional stage and in the early stages of pregnancy; to identify pathogenetic aspects of the impact of imbalance of these substances on the processes of pregnancy loss; to assess the possibility of correcting the identifi ed changes in the preconceptional stage. Materials and methods. The study was conducted in 2 phases. In the fi rst phase, 426 women with CE were studied (168 patients (group I) were treated for CE in the preconception period, and the rest, 258 patients (group II), did not receive treatment). The control group consisted of 30 healthy women. The levels of cytokines TNF-a, INF-γ, and IL-10 in cervical mucus and glycodelin in menstrual blood were determined by enzyme- linked immunosorbent assay. In the second phase of the study, women who became pregnant were followed: 135 women from group I who received preconceptional treatment for CE; 168 women from group II who became pregnant along with untreated CE; and 20 healthy women from the control group who became pregnant and subsequently had no complications. At 5-6 weeks of gestation, serum glycodelin concentration and cervical content levelsof TNF-a, INF-γ and IL-10 were determined. The data were processed using mathematical statistical methods, Student’s t-test, Pearson’s correlation coeffi cient (r) and odds ratio were evaluated using the STATISTICA program of StatSoft Inc. (USA). The study adhered to the tenets of the Declaration of Helsinki. The study protocol was approved by the local ethics committee of PSMU for all women enrolled in this study. The article is extracted from the initiative scientifi c research project of the Obstetrics and Gynecology Department No 2 of the Poltava State Medical University «Optimization of approaches to pregnancy management in women at high risk of obstetric and perinatal pathology» (term: 2022-2027; state registration number 0122U201228).Results and Discussion. At the preconceptional stage, patients with CE showed a signifi cant decrease in glycodelin levels by 2.9 times (p<0.05), an increase in proinfl ammatory cytokines (INF-γ by 2.8 times (p<0.001), TNF-α by half (p<0.001)), and a decrease in IL-10 by 2 times (p<0.001) compared to the levels in healthy non-pregnant women. A decrease in the level of glycodelin in menstrual blood of women with CE is inversely correlated with an increase in the level of proinfl ammatory cytokines in cervical mucus (both INF-γ; r= –0.77; p<0.05, and TNF-α; r= –0.69; p<0.05). At 5-6 weeks of gestation, the level of serumglycodelin was 14.5 % lower (р˂0.05) in patients with pregestational untreated CE and 58.6 % lower (p<0.001) in women with early pregnancy loss. The level of this protein in menstrual blood of women with CE before pregnancy was positively correlated with its concentration in serum at 5-6 weeks of pregnancy (r=0.61; p<0.01). Such a relationship was also characteristic for INF-γ (r=0.68; p<0.05) and TNF-α (r=0.78; p<0.05). An inverse correlation was also found between a decrease in glycodelin levels in the blood of pregnant women with a history of untreated CE at 5-6 weeks of pregnancy and an increase in TNF-α (r= –0.63; p<0.05) and INF-γ (r= –0.57; p<0.05) in the cervical mucus of these pregnant women at this stage of pregnancy. After treatment for CE, both in the preconceptional stage and in early pregnancy, an increase in glycodelin (р˂0.001), a decrease in INF-γ (p<0.05) and TNF-α (p<0.01), and an increase in IL-10 concentration (р˃0.05) were observed. The incidence of spontaneous abortion before 22 weeks’ gestation decreased 1.9-fold in women who received preconception treatment (OR 2.79; CI 95 % [1.45-5.38]; p < 0.05).Conclusions. In women with CE, there is a decrease in glycodelin synthesis and cytokine imbalance with an increase in proinfl ammatory cytokines: INF-γ (2.8-fold; р˃0.001) and TNF-α (twofold; p<0.001). The preconceptional decrease in glycodelin synthesis correlates with a decrease in synthesis of this protein by decidual cells after pregnancy, as well as with the prevalence of INF-γ and TNF-α in early pregnancy in women with a history of CE. This sets the stage for impaired immune tolerance between the uterus and the fetus and is one of the leading causes of spontaneous abortion in women who become pregnant with untreated CE. Preconceptional treatment of CE prevents the formation of cytokine imbalance and increases glycodelin synthesis in the early stages of pregnancy, which protects the course of pregnancy and reduces the incidence of early preterm labor by 4.6 times.\",\"PeriodicalId\":162458,\"journal\":{\"name\":\"Neonatology, surgery and perinatal medicine\",\"volume\":\" 21\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neonatology, surgery and perinatal medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24061/2413-4260.xiv.2.52.2024.9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neonatology, surgery and perinatal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24061/2413-4260.xiv.2.52.2024.9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
慢性子宫内膜炎在自然流产,尤其是习惯性流产的妇女中发病率特别高。关于伴随这种病症怀孕的妇女的流产机制,目前还没有足够的数据。目的:评估患有 CE 的妇女在孕前和妊娠早期细胞因子和子宫内膜蛋白的合成水平;确定这些物质的失衡对妊娠失败过程的影响的病理方面;评估在孕前阶段纠正已确定的变化的可能性。材料和方法研究分两个阶段进行。第一阶段研究了 426 名患有 CE 的妇女(168 名患者(I 组)在孕前接受了 CE 治疗,其余 258 名患者(II 组)未接受治疗)。对照组由 30 名健康妇女组成。宫颈粘液中细胞因子 TNF-a、INF-γ 和 IL-10 的水平以及月经血中甘油三酯的水平通过酶联免疫吸附试验进行了测定。在研究的第二阶段,对怀孕的妇女进行了跟踪调查:第一组的 135 名妇女接受了宫颈癌的孕前治疗;第二组的 168 名妇女在怀孕的同时未接受宫颈癌治疗;对照组的 20 名健康妇女在怀孕后未出现并发症。在妊娠5-6周时,测定血清中甘油三酯的浓度以及宫颈中TNF-a、INF-γ和IL-10的含量。数据采用数理统计方法进行处理,使用 StatSoft 公司(美国)的 STATISTICA 程序进行学生 t 检验、皮尔逊相关系数(r)和几率比。本研究遵循《赫尔辛基宣言》的原则。所有参加本研究的妇女的研究方案均已获得 PSMU 当地伦理委员会的批准。本文摘自波尔塔瓦国立医科大学妇产科二系的科研项目 "产科和围产期病理高风险妇女妊娠管理方法的优化"(期限:2022-2027 年;国家注册号:0122U201228)。在孕前阶段,与健康非孕妇相比,CE 患者的甘油三酯水平明显下降 2.9 倍(p<0.05),促炎症细胞因子增加(INF-γ 增加 2.8 倍(p<0.001),TNF-α 增加一半(p<0.001)),IL-10 下降 2 倍(p<0.001)。宫颈癌妇女月经血中甘油三酯水平的下降与宫颈粘液中促炎细胞因子水平的上升成反比(INF-γ;r= -0.77;p<0.05;TNF-α;r= -0.69;p<0.05)。在妊娠 5-6 周时,孕前未治疗 CE 患者的血清甘油三酯水平降低了 14.5%(р˂0.05),而早孕流产妇女的血清甘油三酯水平降低了 58.6%(p<0.001)。患有 CE 的妇女怀孕前月经血中该蛋白质的水平与怀孕 5-6 周时血清中该蛋白质的浓度呈正相关(r=0.61;p<0.01)。INF-γ(r=0.68;p<0.05)和 TNF-α(r=0.78;p<0.05)也具有这种关系。还发现,在怀孕 5-6 周时,有 CE 病史且未接受过治疗的孕妇血液中甘油三酯水平的下降与这些孕妇在此阶段宫颈粘液中 TNF-α (r= -0.63; p<0.05) 和 INF-γ (r= -0.57; p<0.05) 的增加之间存在反相关关系。经过 CE 治疗后,无论是在孕前阶段还是在孕早期,都观察到甘油三酯增加(р˂0.001),INF-γ(p<0.05)和 TNF-α (p<0.01)下降,IL-10 浓度增加(р˃0.05)。接受孕前治疗的妇女在妊娠 22 周前自然流产的发生率降低了 1.9 倍(OR 2.79;CI 95 % [1.45-5.38];p <0.05)。患有 CE 的妇女体内糖原合成减少,细胞因子失衡,促炎症细胞因子增加:INF-γ(2.8 倍;р˃0.001)和 TNF-α(2 倍;p<0.001)。孕前糖醛酸合成的减少与怀孕后蜕膜细胞合成该蛋白的减少以及有 CE 史的妇女在孕早期 INF-γ 和 TNF-α 的流行有关。这为子宫和胎儿之间的免疫耐受能力受损埋下了伏笔,也是妊娠合并 CE 且未经治疗的妇女自然流产的主要原因之一。对 CE 进行孕前治疗可防止细胞因子失衡的形成,并在妊娠早期增加糖原蛋白的合成,从而保护妊娠过程,并将早期早产的发生率降低 4.6 倍。
PREREQUISITES FOR EARLY PREGNANCY LOSS IN WOMEN WITH CHRONIC ENDOMETRITIS
The incidence of chronic endometritis is particularly high in women with spontaneous abortions, especially habitual ones. There are insuffi cient data on the mechanisms of miscarriage in women whose pregnancy occurred along with this pathology. Aim: to assess the level of synthesis of cytokines and endometrial proteins in women with CE in the preconceptional stage and in the early stages of pregnancy; to identify pathogenetic aspects of the impact of imbalance of these substances on the processes of pregnancy loss; to assess the possibility of correcting the identifi ed changes in the preconceptional stage. Materials and methods. The study was conducted in 2 phases. In the fi rst phase, 426 women with CE were studied (168 patients (group I) were treated for CE in the preconception period, and the rest, 258 patients (group II), did not receive treatment). The control group consisted of 30 healthy women. The levels of cytokines TNF-a, INF-γ, and IL-10 in cervical mucus and glycodelin in menstrual blood were determined by enzyme- linked immunosorbent assay. In the second phase of the study, women who became pregnant were followed: 135 women from group I who received preconceptional treatment for CE; 168 women from group II who became pregnant along with untreated CE; and 20 healthy women from the control group who became pregnant and subsequently had no complications. At 5-6 weeks of gestation, serum glycodelin concentration and cervical content levelsof TNF-a, INF-γ and IL-10 were determined. The data were processed using mathematical statistical methods, Student’s t-test, Pearson’s correlation coeffi cient (r) and odds ratio were evaluated using the STATISTICA program of StatSoft Inc. (USA). The study adhered to the tenets of the Declaration of Helsinki. The study protocol was approved by the local ethics committee of PSMU for all women enrolled in this study. The article is extracted from the initiative scientifi c research project of the Obstetrics and Gynecology Department No 2 of the Poltava State Medical University «Optimization of approaches to pregnancy management in women at high risk of obstetric and perinatal pathology» (term: 2022-2027; state registration number 0122U201228).Results and Discussion. At the preconceptional stage, patients with CE showed a signifi cant decrease in glycodelin levels by 2.9 times (p<0.05), an increase in proinfl ammatory cytokines (INF-γ by 2.8 times (p<0.001), TNF-α by half (p<0.001)), and a decrease in IL-10 by 2 times (p<0.001) compared to the levels in healthy non-pregnant women. A decrease in the level of glycodelin in menstrual blood of women with CE is inversely correlated with an increase in the level of proinfl ammatory cytokines in cervical mucus (both INF-γ; r= –0.77; p<0.05, and TNF-α; r= –0.69; p<0.05). At 5-6 weeks of gestation, the level of serumglycodelin was 14.5 % lower (р˂0.05) in patients with pregestational untreated CE and 58.6 % lower (p<0.001) in women with early pregnancy loss. The level of this protein in menstrual blood of women with CE before pregnancy was positively correlated with its concentration in serum at 5-6 weeks of pregnancy (r=0.61; p<0.01). Such a relationship was also characteristic for INF-γ (r=0.68; p<0.05) and TNF-α (r=0.78; p<0.05). An inverse correlation was also found between a decrease in glycodelin levels in the blood of pregnant women with a history of untreated CE at 5-6 weeks of pregnancy and an increase in TNF-α (r= –0.63; p<0.05) and INF-γ (r= –0.57; p<0.05) in the cervical mucus of these pregnant women at this stage of pregnancy. After treatment for CE, both in the preconceptional stage and in early pregnancy, an increase in glycodelin (р˂0.001), a decrease in INF-γ (p<0.05) and TNF-α (p<0.01), and an increase in IL-10 concentration (р˃0.05) were observed. The incidence of spontaneous abortion before 22 weeks’ gestation decreased 1.9-fold in women who received preconception treatment (OR 2.79; CI 95 % [1.45-5.38]; p < 0.05).Conclusions. In women with CE, there is a decrease in glycodelin synthesis and cytokine imbalance with an increase in proinfl ammatory cytokines: INF-γ (2.8-fold; р˃0.001) and TNF-α (twofold; p<0.001). The preconceptional decrease in glycodelin synthesis correlates with a decrease in synthesis of this protein by decidual cells after pregnancy, as well as with the prevalence of INF-γ and TNF-α in early pregnancy in women with a history of CE. This sets the stage for impaired immune tolerance between the uterus and the fetus and is one of the leading causes of spontaneous abortion in women who become pregnant with untreated CE. Preconceptional treatment of CE prevents the formation of cytokine imbalance and increases glycodelin synthesis in the early stages of pregnancy, which protects the course of pregnancy and reduces the incidence of early preterm labor by 4.6 times.